nct_id,organization,name,email,phone
NCT02268994,"Keryx Biopharmaceuticals, Inc.",Keryx Medical Information,medicalinfo@keryx.com,1-844-44-KERYX (844-445-3799)
NCT00462384,Hoffmann-La Roche,Medical Communications,genentech@druginfo.com,800-821-8590
NCT02378662,Aevi Genomic Medicine,"Garry A. Neil, MD",garry.neil@aevigenomics.com,610-254-4208
NCT00364845,Amgen Inc.,Study Director,NA,866-572-6436
NCT01155388,"AMAG Pharmaceuticals, Inc.",Medical Information,CTInterest@covispharma.com,NA
NCT00337935,Centocor Ortho-Biotech LLC.,"Vice President, Medical Affairs",NA,800.457.6399
NCT01903148,Hospital de Bellvitge,Dr. Alberto Mart√≠nez Castelao,albertomcastelao@gmail.com,610 459 262
NCT00258427,"Masonic Cancer Center, University of Minnesota","Margaret L. MacMillan, M.D.",macmi002@umn.edu,612-273-2800
NCT00559273,Hoffmann-La Roche,Medical Communications,genentech@druginfo.com,800-821-8590
NCT01244763,"FibroGen, Inc.",Clinical Trial Information Desk,NA,415-978-1441
NCT02879305,GlaxoSmithKline,GSK Response Center,GSKClinicalSupportHD@gsk.com,866-435-7343
NCT00968617,"Merck, Sharp & Dohme Corp.","Senior Vice President, Global Clinical Development",ClinicalTrialsDisclosure@merck.com,NA
NCT00924781,"Merck, Sharp & Dohme Corp.","Senior Vice President, Global Clinical Development",ClinicalTrialsDisclosure@merck.com,NA
NCT02468414,Aevi Genomic Medicine,"Garry A. Neil, MD",garry.neil@aevigenomics.com,610-254-4208
NCT01264679,"AMAG Pharmaceuticals, Inc.",Medical Information,CTInterest@covispharma.com,NA
NCT03461146,Mitsubishi Tanabe Pharma Corporation,"Clinical Trials, Information Desk",cti-inq-ml@ml.mt-pharma.co.jp,+81-3-5960-9608 Japanese only
NCT02689206,GlaxoSmithKline,GSK Response Center,GSKClinicalSupportHD@gsk.com,866-435-7343
NCT02829320,GlaxoSmithKline,GSK Response Center,GSKClinicalSupportHD@gsk.com,866-435-7343
NCT00422513,Hoffman-LaRoche,Medical Communications,NA,800-821-8590
NCT00548691,"Luitpold Pharmaceuticals, Inc.","Mark Falone, MD",mfalone@luitpold.com,610-650-4200
NCT00479115,Cincinnati Children's Hospital Medical Center,"Stella Davies, MBBS, PhD, MRCP",Stella.Davies@cchmc.org,513-636-1371
NCT01146574,Bristol-Myers Squibb,Bristol-Myers Squibb Study Director,Clinical.Trails@bms.com,Please email
NCT00981045,"Luitpold Pharmaceuticals, Inc.","Mark A. Falone, MD",mfalone@luitpold.com,610-650-4200
NCT03409107,GlaxoSmithKline,GSK Response Center,GSKClinicalSupportHD@gsk.com,866-435-7343
NCT02876835,GlaxoSmithKline,GSK Response Center,GSKClinicalSupportHD@gsk.com,866-435-7343
NCT01102413,Pharmacosmos A/S,Vice President Research & Development Department,llt@pharmacosmos.com,+45 59485959
NCT01940484,Hoffmann-LaRoche,Medical Communications,genentech@druginfo.com,800-821-8590
NCT03398824,Boston Children's Hospital,Akiko Shimamura,akiko.shimamura@childrens.harvard.edu,617-919-6946
NCT00925587,Amgen Inc.,Study Director,NA,866-572-6436
NCT01001598,Boston Children's Hospital,Colin A. Sieff,colin.sieff@childrens.harvard.edu,617 919-4241
NCT01887600,Astellas Pharma Europe B.V. (APEB),Clinical Trial Disclosure,astellas.resultsdisclosure@astellas.com,31 (0) 715455050
NCT00236977,"Luitpold Pharmaceuticals, Inc.","Mark A. Falone, MD",mfalone@luitpold.com,610-650-4200
NCT00354341,Hoffmann-LaRoche,Medical Communications,genentech@druginfo.com,800-821-8590
NCT01587924,GlaxoSmithKline,GSK Response Center,NA,866-435-7343
NCT00317239,"Luitpold Pharmaceuticals, Inc.",Mark Falone,mfalone@luitpold.com,610-650-4200
NCT00167388,University of Pittsburgh,Dr. Toby Yanowitz,yanotd@mail.magee.edu,412-641-4111
NCT02648347,"Akebia Therapeutics, Inc.",Clinical Trial Information Desk,trials@akebia.com,+1 617-844-6128
NCT00746551,"Mahidol University, Department of Obstetrics and Gynaecology, Division of Maternal Fetal Medicine, Faculty of Medicine, Siriraj Hospital",Pharuhas Chanprapaph,pharuhasc@gmail.com,+66819920053
NCT00317226,"Luitpold Pharmaceuticals, Inc.","Mark Falone, MD",mfalone@luitpold.com,610-650-4200
NCT01422824,Hoffmann-LaRoche,Medical Communications,genentech@druginfo.com,800 821-8590
NCT00395993,"Luitpold Pharmaceuticals, Inc.","Mark A. Falone, MD",mfalone@luitpold.com,610-650-4200
NCT02128074,"Keryx Biopharmaceuticals, Inc",Keryx Medical Information,medicalinfo@keryx.com,1-844-44-KERYX (844-445-3799)
NCT02865850,"Akebia Therapeutics, Inc.",Clinical Trial Information Desk,trials@akebia.com,+1 617-844-6128
NCT04410198,"FibroGen, Inc.",Clinical Trial Information Desk,FG4592-097Study@fibrogen.com,415-978-1441
NCT00590460,BAYLOR,"Malcolm Brenner, MD",mbrenner@bcm.edu,832-824-4663
NCT03439137,Mitsubishi Tanabe Pharma Corporation,"Clinical Trials, Information Desk",cti-inq-ml@ml.mt-pharma.co.jp,+81-3-5960-9608 Japanese only
NCT03402386,Mitsubishi Tanabe Pharma Corporation,"Clinical Trials, Information Desk",cti-inq-ml@ml.mt-pharma.co.jp,+81-3-5960-9608 Japanese only
NCT03329196,Mitsubishi Tanabe Pharma Corporation,"Clinical Trials, Information Desk",cti-inq-ml@ml.mt-pharma.co.jp,+81-3-5960-9608 Japanese only
NCT02278341,Astellas Pharma Europe B.V.,Clinical Trial Disclosure,astellas.resultsdisclosure@astellas.com,800-888-7704
NCT00630253,"Masonic Cancer Center, University of Minnesota","Margaret L. MacMillan, M.D.",macmi002@umn.edu,612-273-2800
NCT01902628,Hoffmann-La Roche,Medical Communications,genentech@druginfo.com,1-800-821-8590
NCT02940860,Pharmacosmos A/S,Clinical trial disclosure desk,trial@pharmacosmos.com,+45 5948 5935
NCT02038023,AUERBACH HEMATOLOGY ONCOLOGY ASSOC,Dr Michael AUERBACH,MAUERBACHMD@ABHEMONC.COM,410-780-4050
NCT01381094,"Akebia Therapeutics, Inc.","Akebia Therapeutics, Inc.",trials@akebia.com,+1 617-844-6128
NCT01235936,"Akebia Therapeutics, Inc","Akebia Therapeutics, Inc",trials@akebia.com,617-844-6128
NCT03799627,"Akebia Therapeutics, Inc","Akebia Therapeutics, Inc",trials@akebia.com,617-844-6128
NCT00436748,Amgen Inc.,Study Director,NA,866-572-6436
NCT02625844,Hoffmann-La Roche,Medical Communications,genentech@druginfo.com,800 821-8590
NCT02075463,GlaxoSmithKline,GSK Response Center,NA,866-435-7343
NCT03408639,CinnaGen Co.,Dr. Nassim Anjidani,Anjidani.N@orchidpharmed.com,00989125477964
NCT01977573,GlaxoSmithKline,GSK Response Center,NA,866-435-7343
NCT01155375,"AMAG Pharmaceuticals, Inc.",Medical Information,amag@druginfo.com,+1-877-411-2510
NCT04484857,"FibroGen, Inc.",Clinical Trial Information Desk,FG4592-096Study@fibrogen.com,415-978-1441
NCT03670537,Auerbach Hematology and Oncology,Michael Auerbach,mauerbachmd@abhemonc.com,4107804050
NCT03140722,Akebia Therapeutics,Akebia Therapeutics,trials@akebia.com,(617) 844-6128
NCT03054350,Akebia Therapeutics,Akebia Therapeutics,trials@akebia.com,(617) 844-6128
NCT01587898,GlaxoSmithKline,GSK Response Center,NA,866-435-7343
NCT00595127,Memorial Sloan Kettering Cancer Center,"Farid Boulad, MD, Attending",bouladf@mskcc.org,+1212-639-2429
NCT02968368,Shield Therapeutics,Jackie Mitchell MA DPhil,jmitchell@shieldtx.com,+44 (0) 191 511 8515
NCT03400033,GlaxoSmithKline,GSK Response Center,GSKClinicalSupportHD@gsk.com,866-435-7343
NCT02892149,"Akebia Therapeutics, Inc.",Clinical Trial Information Desk,trials@akebia.com,+1 617-844-6128
NCT03552393,Hoffmann-La Roche,Medical Communications,genentech@druginfo.com,800 821-8590
NCT00717366,Hoffmann-La Roche,Medical Communications,genentech@druginfo.com,800-821-8590
NCT00352976,"Masonic Cancer Center, University of Minnesota","Margaret L. MacMillan, M.D.",macmi002@umn.edu,612-626-2961
NCT00318812,Ottawa Hospital Research Institute,"Dr Deborah Zimmerman, principal investigator",dzimmerman@toh.on.ca,613-738-8400
NCT03029208,GlaxoSmithKline,GSK Response Center,GSKClinicalSupportHD@gsk.com,866-435-7343
NCT00440557,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",Sr Director of Clinical Research,NA,908-927-2116
NCT00701714,Sandoz,"Biopharmaceutical Clinical Development, Strategic Planning",biopharma.clinicaltrials@sandoz.com,0049 80244760
NCT02260193,"Akebia Therapeutics, Inc.","Akebia Therapeutics, Inc.",trials@akebia.com,+1 617-844-6128
NCT00752609,"Takeda Global Research and Development Center, Inc.","Sr. VP, Clinical Science",clinicaltrialregistry@tpna.com,800-778-2860
NCT01379963,Hoffmann-LaRoche,Medical Communications,genentech@druginfo.com,800-821-8590
NCT03029247,GlaxoSmithKline,GSK Response Center,GSKClinicalSupportHD@gsk.com,8664357343
NCT02174627,AstraZeneca,Global Clinical Lead,ClinicalTrialTransparency@astrazeneca.com,+1 302 885 1180
NCT02021318,Astellas Pharma Europe B.V.,Clinical Trial Disclosure,Astellas.resultsdisclosure@astellas.com,+44 (0)20 3379 8000
NCT03054337,Akebia Therapeutics,Akebia Therapeutics,trials@akebia.com,(617) 844-6128
NCT02969655,GlaxoSmithKline,GSK Response Center,GSKClinicalSupportHD@gsk.com,866-435-7343
NCT01977482,GlaxoSmithKline,GSK Response Center,NA,866-435-7343
NCT02019719,GlaxoSmithKline,GSK Response Center,NA,866-435-7343
NCT02817555,Eastern Health,Andrea Woodland,andrea.woodland@easternhealth.ca,7097778146
NCT01906489,Akebia Therapeutics,Akebia Therapeutics,trials@akebia.com,617-844-6128
NCT00167206,"Masonic Cancer Center, University of Minnesota","Margaret MacMillan, M.D.",macmi002@umn.edu,612-626-2778
NCT01519947,Hoffmann-La Roche,Medical Communications,genentech@druginfo.com,800 821-8590
NCT00548860,"Luitpold Pharmaceuticals, Inc.","Mark Falone, MD",mfalone@luitpold.com,610-650-4200
NCT01750190,"FibroGen, Inc.",Clinical Trial Information Desk,060study@fibrogen.com,415-978-1441
NCT03446612,GlaxoSmithKline,GSK Response Center,GSKClinicalSupportHD@gsk.com,866-435-7343
NCT00994318,Vifor Pharma,Medical Information,medinfo@viforpharma.com,41 58 851 8222
NCT02680574,"Akebia Therapeutics, Inc.",Clinical Trial Information Desk,trials@akebia.com,+1 617-844-6128
